Novel and Enhanced Modalities for Optic Nerve Imaging

SOL #: ARPA-H-SS-26-157Sources Sought

Overview

Buyer

Health And Human Services
National Institutes Of Health
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Washington, DC, 20005, United States

Place of Performance

Washington, DC

NAICS

Research and Development in the Physical (541715)

PSC

Health R&D Services; Health Care Services; Experimental Development (AN13)

Set Aside

No set aside specified

Timeline

1
Posted
May 18, 2026
2
Response Deadline
Jun 10, 2026, 9:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Advanced Research Projects Agency for Health (ARPA-H), under the Health Science Futures Office (HSF), has issued a Sources Sought notice for Novel and Enhanced Modalities for Optic Nerve Imaging. This initiative aims to identify technologies capable of tracking optic nerve growth in vivo to support the Transplantation of Human Eye Allografts Program (THEA). Responses are due by June 10, 2026, 5:00 PM ET.

Purpose & Scope

ARPA-H seeks to gauge industry interest and capabilities in advanced optic nerve imaging. The primary goal is to overcome current limitations in tracking optic nerve repair and regrowth, which is crucial for enabling whole eye transplantation. Specifically, the government is interested in:

  • Technologies for single axon resolution imaging to track optic nerve growth.
  • Potential enhancements to existing MRI/PET for single axon resolution.
  • Modalities capable of capturing the optic nerve, chiasm, optic tract, and early visual system targets in a single image.
  • Modalities ready for human clinical trials within two years.
  • Methods to differentiate native retinal ganglion cells from transplanted cells.

Submission Requirements

Responses should not exceed 6 pages (single-spaced, 12-point font, 1-inch margins) and must be emailed to THEA@arpa-h.gov by the deadline. The subject line should be "Sources Sought Response: Novel and Enhanced Modalities for Optic Nerve Imaging" followed by the institution's name. Submissions should include:

  • Contact information, CAGE Code, Unique Entity ID, and DUNS Number (if applicable).
  • Anticipated NAICS Code: 541715.
  • A concise technical description of capabilities or R&D needs.
  • Indication of interest in a future Request for Proposal (RFP) as prime or subcontractor.
  • Information on subcontracting possibilities.
  • Summaries of at least two relevant past performance contracts (within 36 months).
  • Information on active government contracts.
  • A rough estimate or cost range of the annual cost.
  • Indication of ability to provide the requirement post-award.

Contract & Timeline

  • Type: Sources Sought / Request for Information
  • Set-Aside: None specified (market research stage)
  • Response Due: June 10, 2026, 5:00 PM ET
  • Published: May 18, 2026
  • Product Service Code: AN13 (Health R&D Services; Health Care Services; Experimental Development)
  • Department/Agency: Health And Human Services / ARPA-H

Important Note

This is a Request for Information only, intended for planning purposes. It does not constitute a commitment to a future procurement, and no reimbursement will be provided for response costs.

People

Points of Contact

The THEA TeamPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Sources Sought
Posted: May 18, 2026
Novel and Enhanced Modalities for Optic Nerve Imaging | GovScope